596 related articles for article (PubMed ID: 33517820)
1. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.
Ma H; Jiang Z; Xu J; Liu J; Guo ZN
Drug Deliv; 2021 Dec; 28(1):357-371. PubMed ID: 33517820
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
Liu S; Feng X; Jin R; Li G
Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
[TBL] [Abstract][Full Text] [Related]
3. Novel and emerging therapies: thrombus-targeted fibrinolysis.
Lippi G; Mattiuzzi C; Favaloro EJ
Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke.
Zamanlu M; Farhoudi M; Eskandani M; Mahmoudi J; Barar J; Rafi M; Omidi Y
J Drug Target; 2018 Feb; 26(2):95-109. PubMed ID: 28796540
[TBL] [Abstract][Full Text] [Related]
5. Thrombolytic strategies for ischemic stroke in the thrombectomy era.
Gauberti M; Martinez de Lizarrondo S; Vivien D
J Thromb Haemost; 2021 Jul; 19(7):1618-1628. PubMed ID: 33834615
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Targeted Nanotherapies for Ischemic Stroke.
Liao J; Li Y; Luo Y; Meng S; Zhang C; Xiong L; Wang T; Lu Y
Mol Pharm; 2022 Sep; 19(9):3026-3041. PubMed ID: 35905397
[TBL] [Abstract][Full Text] [Related]
7. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activation and thrombolysis for ischemic stroke.
Medcalf RL; Davis SM
Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
[TBL] [Abstract][Full Text] [Related]
9. Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection.
Yu W; Yin N; Yang Y; Xuan C; Liu X; Liu W; Zhang Z; Zhang K; Liu J; Shi J
Acta Biomater; 2022 Mar; 140():625-640. PubMed ID: 34902617
[TBL] [Abstract][Full Text] [Related]
10. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
[TBL] [Abstract][Full Text] [Related]
11. In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model.
Hua X; Zhou L; Liu P; He Y; Tan K; Chen Q; Gao Y; Gao Y
J Thromb Thrombolysis; 2014 Jul; 38(1):57-64. PubMed ID: 24671732
[TBL] [Abstract][Full Text] [Related]
12. Development of a carotid artery thrombolysis stroke model in mice.
Maclean JAA; Tomkins AJ; Sturgeon SA; Hofma BR; Alwis I; Samson AL; Schoenwaelder SM; Jackson SP
Blood Adv; 2022 Sep; 6(18):5449-5462. PubMed ID: 35767737
[TBL] [Abstract][Full Text] [Related]
13. Metal ion chelation enhances tissue plasminogen activator (tPA)-induced thrombolysis: an in vitro and in vivo study.
Yu X; Wang Z; Li YV
J Thromb Thrombolysis; 2022 Feb; 53(2):291-301. PubMed ID: 34757546
[TBL] [Abstract][Full Text] [Related]
14. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.
Yepes M; Roussel BD; Ali C; Vivien D
Trends Neurosci; 2009 Jan; 32(1):48-55. PubMed ID: 18963068
[TBL] [Abstract][Full Text] [Related]
15. [Recent progress in developing of thrombolytic agents for ischemic stroke].
Xu Y; Chen S; Chen D; Peng S; Cheng Y; Li J; Li Y; Jiang L; Yuan C; Huang M
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):2029-2039. PubMed ID: 33169568
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Chinese herbal medicine for tPA thrombolysis in experimental stroke: A systematic review and meta-analysis.
Ye Y; Zhu YT; Xin XY; Zhang JC; Zhang HL; Li D
Phytomedicine; 2022 Jun; 100():154072. PubMed ID: 35349833
[TBL] [Abstract][Full Text] [Related]
17. Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.
Szegedi I; Orbán-Kálmándi R; Nagy A; Sarkady F; Vasas N; Sik M; Lánczi LI; Berényi E; Oláh L; Crișan A; Csiba L; Bagoly Z
PLoS One; 2021; 16(7):e0254253. PubMed ID: 34234378
[TBL] [Abstract][Full Text] [Related]
18. Advances in thrombolytics for treatment of acute ischemic stroke.
Kirmani JF; Alkawi A; Panezai S; Gizzi M
Neurology; 2012 Sep; 79(13 Suppl 1):S119-25. PubMed ID: 23008386
[TBL] [Abstract][Full Text] [Related]
19. Impact of COVID-19 on thrombus composition and response to thrombolysis: Insights from a monocentric cohort population of COVID-19 patients with acute ischemic stroke.
Desilles JP; Solo Nomenjanahary M; Consoli A; Ollivier V; Faille D; Bourrienne MC; Hamdani M; Dupont S; Di Meglio L; Escalard S; Maier B; Blanc R; Piotin M; Lapergue B; Ajzenberg N; Vasse M; Mazighi M; Ho-Tin-Noé B; ; Désilles JP; Mazighi M; Piotin M; Blanc R; Redjem H; Smajda S; Seners P; Escalard S; Delvoye F; Maier B; Hebert S; Ben Maacha M; Hamdani M; Sabben C; Obadia M; Deschildre C; Lapergue B; Consoli A; Rodesch G; Maria F; Coskun O; Lopez D; Bourcier R; Detraz L; Desal H; Roy M; Clavier D; Marnat G; Gariel F; Lucas L; Sibon I; Eugene F; Vannier S; Ferre JC; LeBras A; Raoult H; Paya C; Gauvrit JY; Richard S; Gory B; Barbier C; Vivien D; Touze E; Gauberti M; Blaizot G; Ifergan H; Herbreteau D; Bibi R; Janot K; Charron V; Boulouis G
J Thromb Haemost; 2022 Apr; 20(4):919-928. PubMed ID: 35032088
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine progress in thrombolytic therapy.
Zenych A; Fournier L; Chauvierre C
Biomaterials; 2020 Nov; 258():120297. PubMed ID: 32818824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
